FDA Drug Application (018733) for TALWIN NX by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number018733
Product Number001
FormTABLET;ORAL
DosageEQ 0.5MG BASE;EQ 50MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTALWIN NX
Active IngredientNALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE



Back to FDA Applications sponsored by SANOFI AVENTIS US

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.